Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Tonix Pharm Hldg (TNXP)

$0.46 0.01 (2.16%)

17:12 EDT TNXP Stock Quote Delayed 15 Minutes

Volume:

Previous Close $0.46

Market Cap 3.89M

PE Ratio -0.17

EPS -2.78

Volume (Avg. Vol.) 69,700

Day's Range 0.43 - 0.47

52-Week Range 0.35 - 9.60

Dividend & Yield N/A (N/A)

TNXP Stock Predictions, Articles, and Tonix Pharm Hldg News

From InvestorPlace
From the Web

Nano Cap News: Why Tonix Pharmaceuticals (TNXP) Stock Is Moving Today

By William White, InvestorPlace Writer Dec 7, 2018

Tonix Pharmaceuticals stock has been on a wild ride today since announcing plans for a new public offering priced at $15 billion.

Tonix Pharma files to offer 16.7M shares

From Seeking Alpha Oct 18, 2019

Tonix Pharmaceuticals (NASDAQ:TNXP) has filed to offer 16.7M shares of common stock, along with 7,500 shares of convertible preferred stock. The sole book-runner is A.G.P. Net proceeds estimated at $

15 Healthcare Stocks Moving In Friday's Pre-Market Session

From Benzinga Sep 20, 2019

Gainers Organovo Holdings, Inc. (NASDAQ: ONVO) stock rose 8.4% to $0.31 during Friday's pre-market session. The market cap seems to be at $146.3 million. According to the...

Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Will Have To Spend Its Cash Wisely

From Simply Wall St Sep 18, 2019

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tnxp/tonix-pharmaceuticals-holding/news/tonix-pharmaceuticals-holding-nasdaqtnxp-will-have-to-spend-its-cash-wisely/">Read More...</a></div>

65 Biggest Movers From Yesterday

From Benzinga Sep 18, 2019

Gainers Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares climbed 63.6% to close at $1.80 on Tuesday after the company reported its A-101 45% Topical Solution met all primary and...

TNXP Stock Soars After Announcing License Deal for TNX-1700

From MarketJar Sep 17, 2019

Tonix Pharmaceuticals Holding announced exciting news for its cancer product TNX-1700, driving TNXP stock flying. Learn more inside.

38 Stocks Moving In Tuesday's Mid-Day Session

From Benzinga Sep 17, 2019

Gainers Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares jumped 50% to $1.6499 after the company reported its A-101 45% Topical Solution met all primary and secondary efficacy...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

F

Strong Sell

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!